CSIMarket Company Name, Ticker, Suppliers, else..
 
Kenvue Inc   (NYSE: KVUE)
 
Price: $18.8800 $-0.29 -1.513%
Day's High: $19.100000381469727 Week Perf: -2.33 %
Day's Low: $ 18.83 30 Day Perf: -1.87 %
Volume (M): 26,671,338 52 Wk High: $ 20.82
Volume (M$): $ 0 52 Wk Avg: $17.66
Open: $19.05 52 Wk Low: $14.02



 Market Capitalization (Millions $) 36,287
 Shares Outstanding (Millions) 1,922
 Employees 22,000
 Revenues (TTM) (Millions $) 15,292
 Net Income (TTM) (Millions $) 1,622
 Cash Flow (TTM) (Millions $) 18
 Capital Exp. (TTM) (Millions $) 435

Business Description


Kenvue Inc is a technology company that specializes in providing innovative software solutions for businesses. They offer a range of products and services, including cloud-based applications, data analytics, and cybersecurity solutions. Kenvue Inc is known for their user-friendly interfaces and customizable features, making their products accessible and applicable to various industries. With a focus on continuous improvement and customer satisfaction, Kenvue Inc strives to deliver cutting-edge technology solutions that enhance productivity and streamline business operations.


   Company Address: 1 Kenvue Way Summit 7901 NJ
   Company Phone Number: 874-1200   Stock Exchange / Ticker: NYSE KVUE


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
EPC        1.27% 
HNST        10.11% 
PBH   -0.46%    
PRGO        2.59% 
• View Complete Report
   



Business Update

Albert Invent Unites with Kenvue to Propel Consumer Health Innovation Through AI Technology,

Published Tue, Oct 14 2025 6:54 PM UTC

In an innovative stride towards the future of consumer health products, Albert Invent, a leading frontier AI company, has announced a strategic partnership with Kenvue Inc., the renowned creator of well-known health brands such as Zyrtec, Neutrogena, and Listerine. The partnership aims to revolutionize Kenvue s research and development (R&D) processes by leveraging advanced ...
Business Update

Kenvue Partners with Microsoft to Advance Digital Transformation in Healthcare

Published Thu, Apr 17 2025 6:24 AM UTC

In a strategic move that underscores the growing intersection of technology and healthcare, Kenvue Inc. has announced a five-year collaboration with Microsoft, aimed at transforming its digital operations. The partnership, revealed from the company’s headquarters in Summit, New Jersey, seeks to establish a robust foundation for the integration of advanced artificial intell...
Business Update

Kenvue Fortifies Board as Stock Performance Shows Mixed Signals,

Published Sun, Mar 9 2025 11:56 AM UTC

Kenvue Strengthens Leadership Amidst Varied Market Performance In a significant move to bolster its corporate governance and strategic direction, Kenvue Inc. recently announced the appointment of three new members to its Board of Directors. This decision comes at a pivotal time as the company s stock performance exhibits mixed results when measured against broader market ind...
Business Update

Neutrogena Partners with Leading Dermatologists as Kenvue Faces Financial Challenges in Receivables Management,

Published Fri, Nov 1 2024 12:36 AM UTC

SKILLMAN, N.J. Kenvue Inc. (NYSE: KVUE) has made significant strides in its commitment to skincare innovation by announcing multi-year partnerships with two of the world s most recognizable dermatologists, Dr. Dhaval Bhanusali and Dr. Muneeb Shah. This collaboration is expected to lead to groundbreaking advancements in product development that align with contemporary derma...
Business Update

Dermatology Meets Aesthetics Neutrogenas Strategic Move to Reinvent Skincare

Published Thu, Oct 31 2024 9:36 PM UTC

In a rapidly evolving beauty and skincare market, Neutrogena, a leading brand under Kenvue Inc. is making significant strides by forging strategic partnerships with two of the most recognizable dermatologists, Dr. Dhaval Bhanusali and Dr. Muneeb Shah. This collaborative initiative signifies not merely a marketing tactic, but a comprehensive move to position Neutrogena as a p...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 22.16
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 2.37
Price to Sales (Expected) -
Price to Book 3.42
PEG (TTM) 0.41

Financial Strength Current
Quick Ratio 0.21
Working Capital Ratio 1.13
Leverage Ratio (MRQ) 1.53
Total Debt to Equity 0.15
Interest Coverage (TTM) 8.31
Debt Coverage (TTM) 1.94

Per Share Current
Earnings (TTM) 0.85 $
Revenues (TTM) 7.96 $
Cash Flow (TTM) 0.01 $
Cash 0.56 $
Book Value 5.52 $
Dividend (TTM) 0.83 $

Efficiency Current
Revenue per Employee (TTM) 695,091
Net Income per Employee (TTM) 73,727
Receivable Turnover Ratio (TTM) 6.35
Inventory Turnover Ratio (TTM) 3.69
Asset Turnover Ratio (TTM) 0.57

Profitability Ratios Current
Gross Margin (MRQ) 58.89 %
Operating Margin (MRQ) 19.62 %
Net Margin (MRQ) 12.13 %
Net Cash Flow Margin (MRQ) 0.33 %
Effective Tax Rate (TTM) 26.71 %

Management Effectiveness Current
Return On Assets (TTM) 6.02 %
Return On Investment (TTM) 7.43 %
Return On Equity (TTM) 15.18 %
Dividend Yield 4.39 %
Pay out Ratio (TTM) 97.42 %



Kenvue Inc's Segments
Self Care    43.46 % of total Revenue
Skin Health and Beauty    27.09 % of total Revenue
Essential Health    29.44 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.